Literature DB >> 26854576

The effect of local anesthetic on pro-inflammatory macrophage modulation by mesenchymal stromal cells.

Andrea Gray1, Ileana Marrero-Berrios1, Jonathan Weinberg2, Devasena Manchikalapati2, Joseph SchianodiCola2, Rene S Schloss3, Joel Yarmush2.   

Abstract

Administering local anesthetics (LAs) peri- and post-operatively aims to prevent or mitigate pain in surgical procedures and after tissue injury in cases of osteoarthritis (OA) and other degenerative diseases. Innovative tissue protective and reparative therapeutic interventions such as mesenchymal stromal cells (MSCs) are likely to be exposed to co-administered drugs such as LAs. Therefore, it is important to determine how this exposure affects the therapeutic functions of MSCs and other cells in their target microenvironment. In these studies, we measured the effect of LAs, lidocaine and bupivacaine, on macrophage viability and pro-inflammatory secretion. We also examined their effect on modulation of the macrophage pro-inflammatory phenotype in an in vitro co-culture system with MSCs, by quantifying macrophage tumor necrosis factor (TNF)-α secretion and MSC prostaglandin E2 (PGE2) production. Our studies indicate that both LAs directly attenuated macrophage TNF-α secretion, without significantly affecting viability, in a concentration- and potency-dependent manner. LA-mediated attenuation of macrophage TNF-α was sustained in co-culture with MSCs, but MSCs did not further enhance this anti-inflammatory effect. Concentration- and potency-dependent reductions in macrophage TNF-α were concurrent with decreased PGE2 levels in the co-cultures further indicating MSC-independent macrophage attenuation. MSC functional recovery from LA exposure was assessed by pre-treating MSCs with LAs prior to co-culture with macrophages. Both MSC attenuation of TNF-α and PGE2 secretion were impaired by pre-exposure to the more potent bupivacaine and high dose of lidocaine in a concentration-dependent manner. Therefore, LAs can affect anti-inflammatory function by both directly attenuating macrophage inflammation and MSC secretion and possibly by altering the local microenvironment which can secondarily reduce MSC function. Furthermore, the LA effect on MSC function may persist even after LA removal.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Inflammation; Local anesthetics; Macrophages; Mesenchymal stromal cells

Mesh:

Substances:

Year:  2016        PMID: 26854576      PMCID: PMC4779686          DOI: 10.1016/j.intimp.2016.01.019

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  36 in total

Review 1.  Multipotent mesenchymal stromal cells and the innate immune system.

Authors:  Katarina Le Blanc; Dimitrios Mougiakakos
Journal:  Nat Rev Immunol       Date:  2012-04-25       Impact factor: 53.106

2.  Cytotoxicity of local anesthetics on human mesenchymal stem cells in vitro.

Authors:  Anita Breu; Sebastian Eckl; Wolfgang Zink; Richard Kujat; Peter Angele
Journal:  Arthroscopy       Date:  2013-08-29       Impact factor: 4.772

Review 3.  Anti-inflammatory properties of local anesthetics and their present and potential clinical implications.

Authors:  J Cassuto; R Sinclair; M Bonderovic
Journal:  Acta Anaesthesiol Scand       Date:  2006-03       Impact factor: 2.105

Review 4.  Anesthetic modulation of neuroinflammation in Alzheimer's disease.

Authors:  Junxia X Tang; Maryellen F Eckenhoff; Roderic G Eckenhoff
Journal:  Curr Opin Anaesthesiol       Date:  2011-08       Impact factor: 2.706

5.  The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF.

Authors:  Kai-Uwe Belge; Farshid Dayyani; Alexia Horelt; Maciej Siedlar; Marion Frankenberger; Bernhard Frankenberger; Terje Espevik; Löms Ziegler-Heitbrock
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

6.  Effect of local anaesthetic infiltration with bupivacaine and ropivacaine on wound healing: a placebo-controlled study.

Authors:  João Abrão; Cleverson R Fernandes; Paul F White; Antonio C Shimano; Rodrigo Okubo; Giovanni Bp Lima; José A Bachur; Sérgio B Garcia
Journal:  Int Wound J       Date:  2012-10-24       Impact factor: 3.315

Review 7.  Local anesthetics: review of pharmacological considerations.

Authors:  Daniel E Becker; Kenneth L Reed
Journal:  Anesth Prog       Date:  2012

8.  Bupivacaine induces apoptosis via mitochondria and p38 MAPK dependent pathways.

Authors:  Jun Lu; Shi Yuan Xu; Qing Guo Zhang; Rui Xu; Hong Yi Lei
Journal:  Eur J Pharmacol       Date:  2011-02-12       Impact factor: 4.432

9.  The comparative cytotoxic effects of different local anesthetics on a human neuroblastoma cell line.

Authors:  Arnaud Malet; Marie-Odile Faure; Nathalie Deletage; Bruno Pereira; Jerome Haas; Gregory Lambert
Journal:  Anesth Analg       Date:  2015-03       Impact factor: 5.108

10.  A comparative evaluation of local application of the combination of eutectic mixture of local anesthetics and capsaicin for attenuation of venipuncture pain.

Authors:  Devendra Gupta; Kamal Kishore; Sonal Rastogi; Prabhat K Singh; Anil Agarwal; Uttam Singh
Journal:  Anesth Analg       Date:  2013-02-11       Impact factor: 5.108

View more
  9 in total

1.  A Step-By-Step Surgical Protocol for the Treatment of Perianal Fistula with Adipose-Derived Mesenchymal Stem Cells.

Authors:  Tihomir Georgiev-Hristov; H Guadalajara; M D Herreros; A L Lightner; E J Dozois; M García-Arranz; D García-Olmo
Journal:  J Gastrointest Surg       Date:  2018-07-31       Impact factor: 3.452

Review 2.  Mesenchymal stem cell related therapies for cartilage lesions and osteoarthritis.

Authors:  Rui Zhang; Jie Ma; Jing Han; Weijie Zhang; Jianbing Ma
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

Review 3.  A Review of the Effects of Pain and Analgesia on Immune System Function and Inflammation: Relevance for Preclinical Studies.

Authors:  George J DeMarco; Elizabeth A Nunamaker
Journal:  Comp Med       Date:  2019-12-20       Impact factor: 0.982

4.  Efficacy of subcutaneous lidocaine injection in venous insufficiency: a prospective, randomized, controlled study, and new treatment protocol.

Authors:  Bahar Dernek; Levent Adiyeke; Tahir Mutlu Duymus; Suavi Aydogmus; Fatma Nur Kesiktas; Nurdan Paker
Journal:  J Phys Ther Sci       Date:  2018-06-12

5.  Alginate encapsulation for bupivacaine delivery and mesenchymal stromal cell immunomodulatory cotherapy.

Authors:  Mollie S Davis; Ileana Marrero-Berrios; Isabel Perez; Charles P Rabolli; Palangat Radhakrishnan; Devasena Manchikalapati; Joseph Schianodicola; Hattiyangangadi Kamath; Rene S Schloss; Joel Yarmush
Journal:  J Inflamm Res       Date:  2019-03-12

6.  A controlled release bupivacaine-alginate construct: Effect on chondrocyte hypertrophy conversion.

Authors:  Mollie S Davis; Ileana Marrero-Berrios; Xiomara I Perez; Palangat Radhakrishnan; Devasena Manchikalapati; Khaja Ahmed; Hattiyangangadi Kamath; Rene S Schloss; Joel Yarmush
Journal:  Osteoarthr Cartil Open       Date:  2020-11-19

Review 7.  Effects of immune cells on mesenchymal stem cells during fracture healing.

Authors:  Sabrina Ehnert; Borna Relja; Katharina Schmidt-Bleek; Verena Fischer; Anita Ignatius; Caren Linnemann; Helen Rinderknecht; Markus Huber-Lang; Miriam Kalbitz; Tina Histing; Andreas K Nussler
Journal:  World J Stem Cells       Date:  2021-11-26       Impact factor: 5.326

8.  Alginate-liposomal construct for bupivacaine delivery and MSC function regulation.

Authors:  Mollie S Davis; Ileana Marrero-Berrios; Isabel Perez; Timothy Maguire; Palangat Radhakrishnan; Devasena Manchikalapati; Joseph SchianodiCola; Hattiyangangadi Kamath; Rene S Schloss; Joel Yarmush
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

9.  Anti-Inflammatory Characteristics of Local Anesthetics: Inhibition of TNF-α Secretion of Lipopolysaccharide-Stimulated Leucocytes in Human Blood Samples.

Authors:  Stefan Weinschenk; Carsten Weiss; Justus Benrath; Volker von Baehr; Thomas Strowitzki; Manuel Feißt
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.